Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
MSAC was delisted on the 17th of February, 2023.
44 hedge funds and large institutions have $71.4M invested in Medicus Sciences Acquisition Corp. Class A Ordinary Share in 2021 Q2 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$7.72M |
| 2 |
TP
Third Point
New York
|
+$7.72M |
| 3 |
HM
HealthCor Management
New York
|
+$7.27M |
| 4 |
KC
Kepos Capital
New York
|
+$5.13M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$5.08M |
Top Sellers
MSAC Hedge Fund Activity: Q2 2021 in Review
44 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) for Q2 2021, worth a combined $71.4M.
Buyers outnumbered sellers: 44 funds opened new MSAC positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $7.72M.
- 44 institutional investors held Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $71.4M of Medicus Sciences Acquisition Corp. Class A Ordinary Share stock for Q2 2021.
- 44 funds opened new Medicus Sciences Acquisition Corp. Class A Ordinary Share positions in Q2 2021 and 0 closed out, a net change of +44 holders.
- The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share buyer in Q2 2021 was Adage Capital Partners, an estimated $7.72M added.
Based on aggregated 13F filings for Q2 2021.